Back to search
Excess Abdominal Fat
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Excess Abdominal Fat trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Excess Abdominal Fat trials you may qualify forAssessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Subjects with Excess Abdominal Fat Accumu…
This study will investigate the safety and efficacy of the investigational use of the HydraSolve T2D™ System in improving blood glucose control and insulin resi…
Prospective, baseline-controlled evaluation of the UltraShape Power device for non-invasive fat reduction in flanks.
Prospective, one arm, baseline-controlled, clinical study for the evaluation of the UltraShape Power treatment using the U-Sculpt Power Transducer for non-invas…
Prospective, blinded, one arm, baseline-controlled clinical study for the evaluation of the UltraShape treatment for non-invasive abdominal fat reduction. Stud…
HIV lipodystrophy affects a significant proportion of patients treated with combination antiretroviral therapy (ART) and is characterized by excess visceral fat…
Problematic and state of the art Obesity and its associated non communicable diseases (NCDs) are rising rapidly in middle income countries, such as those in the…